Emma Raducanu won the US Open 2021 without dropping a single set across ten matches as a qualifier — one of the most remarkable sporting achievements of the decade. She then promptly had multiple hand and foot surgeries and spent 18 months ranked outside the top 100. For prediction markets, she is the ultimate uncertainty object: peak evidence of extraordinary talent, sustained evidence of physical fragility.
The Comeback Market
Raducanu's markets are driven by return probability more than anything else. When healthy, her game is legitimately top-20 quality. The question is how often she's healthy, and whether the surgeries have solved her underlying injury pattern or just deferred it. Boromarket's 'Will Raducanu reach a Grand Slam final in 2026?' market has been one of the most discussed on the platform.
The Markets Worth Trading
- →Will Raducanu finish 2026 ranked inside the top 30?
- →Will she win a WTA 500 or higher title in 2026?
- →Grand Slam quarter-final in 2026: Yes or No?
- →Will she be selected to represent Great Britain at the 2028 Olympics?
- →Head-to-head vs top-10 players: win percentage in 2026?
"Raducanu's ceiling is a Grand Slam title. Her floor is another six months of injury. The market has to price the full range every single week."
— WTA market analyst, Boromarket
The Coaching Variable
Raducanu has changed coaches more frequently than almost any top player. Each coaching change generates a short-term price movement in her markets — the market correctly identifies that consistency of coaching matters. The traders who track her coaching situation most carefully have consistently found edge in Boromarket's Raducanu markets.
Raducanu's ranking at the start of each Grand Slam determines her seeding and draw. Lower seeds mean harder draws — which compounds market uncertainty beyond her base talent.